IMU (ASX) Why IMU is a multi multi bagger

Originally posted by Taureanbull ↑

Ben , Thx for your summary of IMU’s current progress towards commercialisation.

I agree with your view that a deal might be a lot closer than we realise. A few of the companies statements seem incongruent around commercialisation though.

When LC first came to IMU she clearly stated her mission in life was to beat cancer. And on the business front she wanted IMU to become a mini-Genentech!

I think those two ambitions are very close to fruition. I don’t believe LC will sell off here babies to other companies to commercialise.

It’s a constant theme for her to relay how her team have taken 14 drugs to the bedside. Thats what the Team Imugene is all about. For them the FDA approvals is like an Olympic Gold medal is to an athlete. Or a Victoria Cross is to a soldier.

Can anybody seriously see LC selling her babies and going out buying a new technology and redoing the last 9 years all over again. NO!.
I also suspect IMU is progressing better than either LC or PH could have envisaged in their wildest dreams even 5 years ago.

Then we see PH putting some shares out amongst the family. He obviously believes IMU has a big future.

When I way all of these aspects up it becomes obvious in my mind that the best deal we can do from here is a Roche/Genentech structured deal. And once that’s announced head over to the Nasdaq. That will be the major catalyst.

By structuring a deal this way we all get what we want. LC builds her Genentech and saves many lives from the ravages of cancer. The owners of the company makes serious returns on our money. Many here reading this have held for years, so an opportunity to take some handsome profits now and leave some in the game must be very attractive

If IMU sold 50% of the company to a BP now they could declare a special dividend to existing holders and the remaining 50% could grow substantially in value over he coming years as our programs become SOC in cancer therapies.

LC dropped a serious hint in her recent video. Which I highlighted in an earlier post a well or so back. She said that Big Pharma and Big Investors were all eyes on IMU’s Oncarlytics. Thats the big prize here. Posts over the last few days by some incredibly talented and hard working posters should give all of us a great deal of confidence in CF / Vaxinia/ Oncarlytics!

These Big Boys of NASAQ Biotechnology will already be engaged. They’ll be looking to see how they can get in on any deals should Oncarlytics play out as expected. It’s game on now.

As the data mounts the pressure will be on for these players to fire the starters gun,

What’s in it for us? Well seeing the deals that have been done recently. And hearing statements this week from the CEO OF MERCK about acquisitions in the $1bn to $15bn ranger to fixe the impending Revenue Cliff Merck and many others are about to go over.

My guess is the minimum we should expect is US$25bn for a 50% slab, There will be a blind auction here. Prices will quickly escalate. That’s more than $4 a share in cash. That can be distributed. But remember we still own 50%. So $4 gets paid out and $4 is retained. We effectively get value at $8.

Them over next 5 years the retained values grow exponentially because we are Nasdaq listed with a Big Brother., Eventually our Big Brother takes out the remaining 50%.

Readers might thinks this is all fantasy but that’s why PH went into the cancer space because that’s where the big money is. And let’s be honest here, that’s why we all followed him into IMU.

Expand

"Readers might thinks this is all fantasy but that’s why PH went into the cancer space because that’s where the big money is. And let’s be honest here, that’s why we all followed him into IMU."

Its not fantasy ! - but very reasonable & considered speculation , supported by just so many clues .....both internal progress made and reported by IMU to date & the enormous value proposition of the IP longer term . Marry this up with the appetite to maintain cash flows longer term by some Big Pharma .....and it all makes a lot of sense .

No.	Vol.	Price($)
2	35252	5.9¢

No.

Vol.

Price($)

35252

5.9¢

Price($)	Vol.	No.
6.0¢	1753430	24

Price($)

Vol.

No.

6.0¢

1753430

No.	Vol.	Price($)
2	35252	0.059
3	727241	0.058
14	2231166	0.057
5	2211114	0.056
22	2671091	0.055

No.

Vol.

Price($)

35252

0.059

727241

0.058

2231166

0.057

2211114

0.056

2671091

0.055

Price($)	Vol.	No.
0.060	1753430	24
0.061	663559	7
0.062	305000	5
0.063	100000	1
0.064	304500	4

Price($)

Vol.

No.

0.060

1753430

0.061

663559

0.062

305000

0.063

100000

0.064

304500

(20min delay)
Last 5.9¢		Change 0.005(9.26%)		Mkt cap ! $433.6M

Open	High	Low	Value	Volume
5.5¢	5.9¢	5.4¢	$1.489M	25.99M

"Readers might thinks this is all fantasy but that’s why PH went...

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nimy to raise $1.21M to explore 'newsy' WA targets

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

"Readers might thinks this is all fantasy but that’s why PH went...

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nimy to raise $1.21M to explore 'newsy' WA targets

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News